NSW Annual Therapeutic Update program now live

22 November 2023



The Pharmaceutical Society of Australia (PSA) has launched the full program of sessions for the New South Wales Annual Therapeutic Update to be held in Magenta Shores from 17-19 February 2024, with early registrations now open.

PSA’s series of Annual Therapeutic Updates provide pharmacists with clinical and practical information on the latest practice developments in their state or territory. Through three days of education, pharmacists will engage with content specifically designed to be relevant within the regulatory environment in New South Wales, including recent changes to pharmacist authorities and upcoming pilot programs.

PSA New South Wales President Luke Kelly FPS urged pharmacists from around the state to take the opportunity to develop their practice as part of their continued professional development.

“The PSA Annual Therapeutic Update is the premier opportunity for pharmacists in all practice settings to stay on top of their clinical knowledge,” Mr Kelly said.

“With the New South Wales Pharmacy Trial set to expand into the treatment of skin conditions in 2024, there has never been a more important time for pharmacists to learn from leaders and continue delivering quality care to our patients.

“I’m confident that all pharmacists, from all corners of our state and from all practice settings will develop new skills and expand their knowledge on topics relevant to daily practice,” Mr Kelly said.

The full program for the 2024 NSW ATU is available here.

PSA has also invited nominations for the NSW Pharmacist of the Year Awards, to be presented during the conference.

Awards are presented to recognise outstanding achievements, innovations, or contributions to the community and pharmacy profession.

“Recognising the skill and dedication of pharmacists is an important part of our role in promoting excellence in pharmacy practice,” Mr Kelly said.

“There are many examples of pharmacists who continue to go above and beyond for patients and for our profession and it is great to be able to recognise some of them in this way.

“I encourage all New South Wales members to recognise the achievements of our fellow pharmacists by making a nomination for the 2024 awards,” Mr Kelly concluded.

Nominations are available here, and close on 19 November 2023.

Event details

  • 17-19 February 2024
  • Pullman Magenta Shores, New South Wales
  • Super early bird registrations open until 22 November 2023 (Professional Plus members save up to 50% on registration price)
  • Register here

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacists applaud NSW red-tape cut and vaccine expansion

27 October 2023


The Pharmaceutical Society of Australia (PSA) welcomes the New South Wales Government’s move to expand vaccination access, with updates to the NSW Pharmacist Vaccination Standards expanding access to National Immunisation Program (NIP) vaccines, lowering minimum age requirements for Shingrix vaccines and removing written consent requirement for COVID-19 vaccines.


PSA New South Wales President Luke Kelly FPS said the changes cut unnecessary red tape, making vaccines more accessible across the state.


“As a state our focus should be on removing barriers to vaccination, cutting the red tape that prevents qualified pharmacist immunisers from delivering more vaccines to more people,” Mr Kelly said.


“I am proud to see years of PSA’s advocacy led to real outcomes not only for the pharmacists who will be able to play a greater role in delivering vaccines, but for our communities who will be able to access eligible vaccines closer to home.


“I thank the NSW Government for moving to expand NIP access for our most vulnerable populations and look forward to continuing to work alongside them to improve vaccine uptake across New South Wales.”


Summary of vaccination changes in NSW:

  • Lowering of the age range that pharmacist immunisers can administer Shingrix vaccine to 18 years and over (was previously 50 years and over) to align with the eligibility for Shingrix vaccine under the NIP.
  • Inclusion of monovalent meningococcal C vaccine for people aged 5 years and over to ensure pharmacist immunisers can provide a full range of meningococcal vaccines to eligible cohorts.
  • Removal of reference to COVID-19 vaccine following the recent inclusion of COVID-19 vaccine in the Australian Immunisation Handbook to be consistent with the approach for all other vaccines that pharmacist immunisers are authorised to immunise.
  • Removal of the COVID-19 vaccine written consent requirements to be consistent with consent requirements for all other vaccines i.e., that informed consent must be obtained, and documented evidence of verbal consent must be made.



Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Ongoing contraceptive supply trial to begin this week

27 September 2023


Following an announcement from Health Minister Ryan Park MP, New South Wales has become the first Australian jurisdiction to authorise the extended supply of oral contraceptives by pharmacists under the NSW Pharmacy Trial.

The Pharmaceutical Society of Australia (PSA) New South Wales President Luke Kelly FPS welcomed the start of the program, which was first announced in November 2022.

“Improving safe access to contraception is essential to improving health care for all Australians,” Mr Kelly said.

“Pharmacists participating in the trial will be able to continue the supply of an existing low-risk contraceptive without renewed prescription, better supporting contraceptive adherence as well as saving patients time and money.

“This trial will make oral contraception more accessible to more women in New South Wales.

“Pharmacists are ready and able to improve healthcare for all Australians, offering safe, accessible, and equitable access to contraception and expert advice on their options.

“Pharmacists are the most accessible health care professional and are well placed to support patients in accessing timely care.

“This is about making sure that Australians can access safe contraception when and where they need it,’ Mr Kelly concluded.


NSW Pharmacists can enrol in the NSW – Contraception Essentials training program here.


For more information on the NSW Pharmacy Trial, visit NSW Health.


Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Better access to medicines a huge win for NSW patients

13 November 2022


The Pharmaceutical Society of Australia (PSA) welcomes today’s announcement from New South Wales Premier Dominic Perrottet, improving access to medicines and vaccines by expanding the scope of practice for NSW pharmacists.


The NSW Government has committed to a 12-month trial allowing pharmacists to prescribe medication for urinary tract infections (UTIs) similar to the program already trialled in Queensland, as well as a state-wide trial of pharmacist prescribing for oral contraceptives, and medication for ear infections and minor skin ailments.


Pharmacists will also be able to administer more vaccinations from Monday 14 November, including Hepatitis A, Hepatitis B, Japanese Encephalitis Virus (JEV), Poliomyelitis, Typhoid, and Zoster vaccines.


PSA NSW President Chelsea Felkai said the move will improve access to medicines and vaccination for residents across NSW, helping to address current GP shortages.


“Giving patients across NSW greater access to vaccinations, contraception and medicines for minor ailments through local pharmacies will significantly improve access to healthcare, especially in regional and rural parts of the state,” Ms Felkai said.


“Trained Queensland pharmacists have been successfully prescribing for uncomplicated UTIs since 2020, giving patients timely access to medicines in an environment where it could otherwise take up to six weeks to get a GP appointment.


“Pharmacists have the skills and expertise to renew patient prescriptions for ongoing health concerns, especially where their chronic condition is stable, removing barriers to medicine access.


“As the most accessible healthcare professional, pharmacists should be able to offer patients renewals of their ongoing medications. Allowing pharmacists to renew prescriptions for oral contraceptives is the first step in giving patients greater access to medicines for stable but chronic conditions that have already been diagnosed.”


Ms Felkai said the community has demonstrated their confidence in pharmacist-administered vaccines throughout the pandemic, with pharmacists now firmly entrenched as part of Australia’s immuniser workforce:


“We share the concerns NSW Health has on the potential for Japanese Encephalitis outbreaks in regional NSW this summer. We are proud that pharmacists will be able to play their part in helping at-risk people protect themselves against this disease.


“While the world has re-opened to travel, the health system remains under significant pressure. Providing patients with more options to access travel vaccinations just makes sense.


“Pharmacists are trained and experienced immunisers. In community pharmacies alone, over 9 million COVID-19 vaccines have been administered, and that doesn’t to count the doses pharmacists have administered in hubs, general practices or aged care facilities.


“This is an important vote of confidence in pharmacists across NSW, in our skills and expertise as part of the primary healthcare team. We thank the NSW Government for their support and look forward to working with the NSW Government to implement these measures.

PSA National President, Dr Fei Sim, also commended the NSW Government on this announcement, and called on other jurisdictions to follow suit.


“PSA has been calling on governments around Australia to allow pharmacists to play a greater role in community health. It’s great to see NSW leading the way in improving patient access to medicines. Pharmacists have the skills and medicine expertise to renew prescriptions for stable, chronic conditions. With ongoing GP shortages across the country, it is time for other jurisdictions to follow NSW’s lead.



Media contact:   Georgia Clarke   M: 0410 505 315     E: georgia.clarke@psa.org.au